← Insider buys
RVNC

Revance Therapeutics, Inc.

SVP, General Counsel and Secretary Dwight Moxie sold $613K of Revance Therapeutics, Inc.

Sold$612,624
$17.58Price
34,853Shares
−44%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Tue, Sep 5. Filed Thu, Sep 7, 1:37 PM ET, during the session. Not investment advice.